Global Pemphigus Vulgaris Market Insights 2025: Key Trends, Market Size, And Growth Forecast

The Business Research Company

The Business Research Company’s Pemphigus Vulgaris Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034

LONDON, GREATER LONDON, UNITED KINGDOM, May 15, 2025 /EINPresswire.com/ -- What Does The Market Size Indicate About The Market Dynamics?
The pemphigus vulgaris market size has grown strongly in recent years. It will grow from $1.80 billion in 2024 to $1.95 billion in 2025 at a compound annual growth rate CAGR of 8.1%. This growth in the historic period can be attributed to increasing adoption of biologic therapies, rising incidence of genetic predisposition, growing prevalence of pemphigus vulgaris, the growing role of biosimilars, and enhancing healthcare infrastructure.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22094&type=smp

How Is The Market Expected To Perform In The Coming Years?
The pemphigus vulgaris market size is expected to witness robust growth in the next few years. It will escalate to $2.63 billion in 2029 at a compound annual growth rate CAGR of 7.8%. This growth during the forecast period can be attributed to the rise in clinical trials, growth in precision medicine, expansion of digital health solutions, increasing demand for biologics, and escalating use of telemedicine. The major trends during this forecast period include advancements in biologic therapies, regulatory approvals, the adoption of combination therapies, the development of personalized medicine, and innovations in oral formulations of biologic therapies.

What Are The Key Market Drivers Propelling The Market Growth?
The prevalence of autoimmune diseases is expected to propel the growth of the pemphigus vulgaris market going forward. Autoimmune diseases are disorders in which the immune system mistakenly attacks and damages the body's healthy cells, tissues, or organs. The prevalence is increasing due to genetic predisposition, environmental triggers, and lifestyle changes. Individuals with a family history of autoimmune diseases are more likely to develop them due to inherited immune system vulnerabilities. More individuals are being diagnosed with conditions like pemphigus vulgaris, driving the demand for advanced therapies. The Mayo Clinic Health System indicates the global incidence and prevalence of autoimmune diseases are rising with annual increases estimated at 19.1% and 12.5%, respectively. Thus, the prevalence of autoimmune diseases is fuelling the growth of the pemphigus vulgaris market.

Who Are The Key Players Dominating The Market?
Major companies operating in the pemphigus vulgaris market include Pfizer Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Amgen Inc., Sanofi S.A, Biogen Inc., Genentech, Genmab A/S, argenx SE, Daewoong Pharmaceutical Co. Ltd., HanAll Biopharma Co. Ltd., Artiva Biotherapeutics, Cabaletta Bio Inc., SinoMab BioScience Limited, Topas Therapeutics GmbH, Principia Biopharma Inc., Serpin Pharma LLC, Syntimmune Inc., and International Pemphigus & Pemphigoid Foundation.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/pemphigus-vulgaris-global-market-report

What Are The Emerging Trends Enhancing Market Growth?
Major companies are focusing on investment solutions to improve treatment efficacy and expand therapeutic options. Investment solutions integrate financial strategies and resources dedicated to treatment development, research, and market introduction. As an example, the Patient Access Network Foundation PAN Foundation launched a financial assistance program offering up to $6,600 per year for eligible patients with pemphigus vulgaris to cover deductibles, copays, and coinsurance costs.

How Is The Market Segmented?
The market is segmented based on Diagnosis And Treatment Diagnosis, Treatment, Population Type Pediatric, Adults, Geriatric, Distribution Channel Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy, and End-User Hospitals, Specialty Clinics, Research Institutes, Other End-Users. The sub-segments include Diagnosis Clinical Examination, Skin Biopsy, Direct Immunofluorescence, Serological Tests, Polymerase Chain Reaction PCR, and Treatment Pharmacological Therapy, Non-Pharmacological Therapy.

What Are The Key Regional Insights?
North America was the largest region in the pemphigus vulgaris market in 2024. Asia-Pacific is envisioned to be the fastest-growing region in the coming years. The regions analyzed in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:
Minimal Residual Disease Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/minimal-residual-disease-testing-global-market-report

Chronic Disease Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/chronic-disease-management-global-market-report

Foot And Mouth Disease Vaccine Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/foot-and-mouth-disease-vaccine-global-market-report

About The Business Research Company
The Business Research Company has over 15000+ reports from 27 industries covering 60+ geographies. With 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, get the information you need to stay ahead.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info|tbrc.info| |info|tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.